We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Platelet Indices Are Associated with Syphilis Activities

By LabMedica International staff writers
Posted on 11 May 2022
Print article
Image: Blood film of platelets that were significantly increased in the primary and secondary syphilis (Photo courtesy of HealthJade)
Image: Blood film of platelets that were significantly increased in the primary and secondary syphilis (Photo courtesy of HealthJade)

Syphilis is caused by Treponema pallidum, which is a chronic sexually transmitted disease that has highly variable clinical courses and manifestations from a painless chancre to severe damage in the brain, heart, and other organs.

Platelet indices have been reported as the important mediators in many infectious diseases. Platelet count (PLT), mean platelet volume (MPV), and platelet distribution width (PDW) are the most commonly used indicators to evaluate platelet activation and function.

Venereologists at the Tongji University School of Medicine (Shanghai, China) and their colleagues conducted a retrospective cohort study the Shanghai Skin Disease Hospital from January 2015 to May 2021. A total of 2,061 patients with syphilis (425 primary and secondary syphilis, 433 latent syphilis, 463 serofast syphilis, 350 asymptomatic neurosyphilis, and 390 symptomatic neurosyphilis, respectively) were enrolled. Among them, 209 patients with neurosyphilis were followed until the end of the treatment. In addition, 528 healthy controls were enrolled during the study, with matched age and sex.

The data of platelet count (PLT), mean platelet volume (MPV), platelet distribution width (PDW), and indicators of syphilis activities were collected. The correlations between the platelet indices and disease activities were analyzed. Data of erythrocyte sedimentation rate (ESR), C-reactive protein CRP, serum rapid plasma reagin (RPR), cerebrospinal fluid- venereal disease research laboratory (CSF VDRL), CSF- white blood cell (CSF-WBC) count, and CSF-protein concentration were collected from patients’ medical records.

The scientists reported that compared with the healthy controls, PLT was significantly increased in the primary and secondary syphilis group; whereas, MPV and PDW were significantly decreased in all stages of syphilis. These changes of platelet indices were reversed after anti-treponemal therapy. Further correlation analysis showed that PLT was positively associated with the syphilis activity indicators: RPR titer, CSF-WBC, CSF-protein, and CSF-VDRL and inflammatory markers: WBC, CRP, and ESR. Conversely, PDW was negatively correlated with all of these parameters. MPV had an inverse relationship with RPR, ESR, and CRP.

The authors concluded that their study provided the first evidence that platelet indices are associated with the disease activities in patients with syphilis. As the modification of platelet indices reflects the change of function, this study may suggest the foundation for further elucidation of the underlying mechanism of how platelets participate in the inflammatory response and pathogenesis of syphilis. The study was published on May 1, 2022 in the International Journal of Infectious Diseases.

Related Links:
Tongji University School of Medicine 

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Lyme Disease Test
Lyme IgG/IgM Rapid Test Cassette
New
Bordetella Pertussis Molecular Assay
Alethia Pertussis

Print article

Channels

Molecular Diagnostics

view channel
Image: The Mirvie RNA platform predicts pregnancy complications months before they occur using a simple blood test (Photo courtesy of Mirvie)

RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms

Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Deliver Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.